Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

Persons > All

Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.

Total search results: 3439 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 32 33 34 35  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Tyler, Christopher (Porvair 200409– Finance Director before Cable & Wireless) Chief Financial Officer (CFO) Porvair (Group) East of England (region)
Tyson, Timothy C. (Valeant 200702 President + CEO) Chief Executive Officer (CEO) Valeant (Group) California (federal state)
Tzalis, Dimitrios (Talos Chemicals 201309 CEO + Founder) Chief Executive Officer (CEO) Taros Chemicals GmbH & Co. KG Nordrhein-Westfalen (federal state)
Tzouliadis, Katie (KTZ Communications 201602 Chief Executive + Founder before Biddick Associates) Public Relations Manager / Investor Relations Manager KTZ Communications Ltd. Greater London (region)
Tzouvalis, Plato (Acrongenomics 200704 President) n. a. Acrongenomics Inc. Greater London (region)
Udier Blagovic, Marina (NousCom 201609– COO before Versant Ventures + Novartis + McKinsey) Chief Operating Officer (COO) Nouscom (Group) Northwestern Switzerland (region)
Ueda, Teruhisa (Shimadzu 201504– CEO before General Manager Analytical + Measuring Instruments division joined 1082) Chief Executive Officer (CEO) Shimadzu (Group) Kinki (region)
Uhlén, Mathias (Royal Institute of Technology (SE) 201509 Professor of Microbiology) Professor
Ujváry, István (iKem 201212 Managing Director + Owner) Managing Director Tarix Pharmaceuticals Ltd. Central Hungary (region)
Umbarger, Ken (Schauenburg 201509 VP Sales + Services Americas for Markes) Sales Manager / Marketing Manager Schauenburg (Group) Connecticut (federal state)
Unalkat, Piyush (EU (govt) 201511 Head of Technology Transfer Investments at EIF) Investment Manager EU (govt) Luxembourg (cl=4)
Underwood, David (Quanticate 201111 CEO) Chief Executive Officer (CEO) Quanticate (Group) East of England (region)
Ureta-Vidal, Abel (Eagle Genomics 201805– Chief Product Officer before CEO + COO + Founder) Product Manager (personnel) Eagle Genomics Ltd. East of England (region)
Usui, Akira (Ray Life Sciences 2007– President + founder before Perlegen Japan + Roche Japan + Tanabe Seiyaku) President/Director/Head Business Group/Unit/Division Ray Life Sciences Inc. (RLS) Japan_o
Utku, Nalân (CellAct Pharma 200707– Managing Director + co-founder before GenPat77 200608 CEO) Managing Director CellAct Pharma GmbH Nordrhein-Westfalen (federal state)
U’Prichard, David C. n. a. Apax Partners (Group) United States (USA)_o
Vachon, Mark (GE Healthcare 200807 President + CEO Global Diagnostic Imaging Business) President/Director/Head Business Group/Unit/Division General Electric (Group) South East England (region)
Vahlgren, Ole (Otsuka 201307 CEO of Otsuka Pharmaceutical Europe Ltd) Chief Executive Officer (CEO) Otsuka (Group) Greater London (region)
Valaskovic, Gary (New Objective 200910 CEO) Chief Executive Officer (CEO) New Objective Inc. Massachusetts (federal state)
Vallance, Patrick (GSK 201302 President Pharmaceuticals RnD) President/Director/Head Business Group/Unit/Division GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
van Antwerpen, Johanna (Amsterdam Innovation Motor 201111 Director) President/Director/Head Business Group/Unit/Division Amsterdam Innovation Motor (AIM) North Holland (province, NL)
Van Beneden, Patrick (GIMV 201306) Investment Manager Gimv (Group) Belgium_o
van Boetzelaer, Alexander (Reed Elsevier 201112 Managing Director of Elsevier Corporate Markets) Managing Director Reed Elsevier (Group) North Holland (province, NL)
Van Bokkelen, Gil (Athersys 2014 CEO) Chief Executive Officer (CEO) Athersys Inc. Ohio (federal state)
van de Stolpe, Onno (Galapagos 200501 CEO) Chief Executive Officer (CEO) Galapagos (Group) Flanders (Flemish region)
van de Zande, Rene (Emergo 200612 President + CEO) Chief Executive Officer (CEO) Emergo Group (Group) Texas (federal state)
van den Berg, Erik (AM-Pharma 201109– CEO before VP Business Development) Chief Executive Officer (CEO) AM-Pharma (Group) Utrecht (province, NL)
Van der Geyten, Serge (JnJ 201501 Director for Neuroscience External Affairs at Janssen Pharmaceutica NV) Business Development Manager / Strategy Manager Johnson & Johnson (JnJ) (Group) Belgium_o
van Geffen, Maarten (Amakem 201207– Head of CMC + Operations before Shire-Movetis + Barrier Therapeutic + Centocor) Chief Operating Officer (COO) Amakem N.V. Flanders (Flemish region)
van Gemen, Bob (Viroclinics Biosciences 201111– CEO before Philips + Primagen + Organon Teknika) Chief Executive Officer (CEO) Primagen (Group) North Holland (province, NL)
Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G) Chief Executive Officer (CEO) Argen-X (Argenx) (Group) North Brabant (province, NL)
Van Herk, Adrianus (Van Herk 201608) n. a. Van Herk (Group) South Holland (province, NL)
van Husen, Georg (Boehringer Ingelheim 201804 SVP Therapeutic Area CardioMetabolism) President/Director/Head Business Group/Unit/Division Boehringer Ingelheim (Group) Rheinland-Pfalz (federal state)
van Mierle, Mark (Reed Elsevier 201301 Managing Director Elsevier Pharmaceutical + Biotech Group) Managing Director Reed Elsevier (Group) North Holland (province, NL)
Van Reet, Gustaaf (Staf) (Viziphar Biosciences 201102 Managing Director + Founder before Movetis + Galapagos + JnJ) Managing Director Viziphar Biosciences (Group) Belgium_o
van Rijsingen, Perry (Philips 201208 General Manager Philips Digital Pathology) General Manager (management) Philips (Group) North Brabant (province, NL)
van Soest, Remco (Eksigent –200704– Product Manager) Product Manager (personnel) Danaher (Group) California (federal state)
van Someren, Alex (Amadeus Capital 201401 Managing Partners of Early Stage funds) Managing Partner (investment firm) Amadeus Capital (Group) Greater London (region)
van Tulder, Arnoud (Cryo-Save 201105 CEO) Chief Executive Officer (CEO) Esperite (Group) Netherlands_o
VanBogelen, Ruth (NextGen 200805– Director Biomarker Proteomics before Pfizer) n. a. NextGen (Group) East of England (region)
Vanhaesebroeck, Bart (Univ London 201004 Professor Institute of Cancer + scientific co-founder Activiomics) Professor University of London Greater London (region)
Vanhove, Bernard (OSE Immunotherapeutics 201707 COO) Chief Operating Officer (COO) OSE Immunotherapeutics (Group) Pays de la Loire (region)
Vann, Christopher (Autolus 201707– COO before Roche) Chief Operating Officer (COO) Autolus Therapeutics plc (Nasdaq: AUTL) Greater London (region)
VanOort, Douglas (NeoGenomics 201703 CEO) n. a. NeoGenomics, Inc. (Nasdaq: NEO) Florida (federal state)
Varley, John (AstraZeneca 200607) n. a. AstraZeneca (Group) Greater London (region)
Vasarotti, Enzo (Vivascience 200008 founder + co-partner) Company Founder Sartorius (Group) East Midlands (region)
Vaschetto, Mariana (Dotmatics 201307 VP Marketing) n. a. Dotmatics (Group) East of England (region)
Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) Board member, non-executive Novartis (Group) Northwestern Switzerland (region)
Vassiliou, Androula (EU 200802– Health Commissioner) Administrative Officer (personnel) EU (govt) Brussels (region)
Vazirani, Suresh (Erba Diagnostics Mannheim 201509 Managing Director) Managing Director Erba Diagnostics Mannheim (Group) Baden-Württemberg (federal state)
Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS) Chief Executive Officer (CEO) Basilea (Group) Northwestern Switzerland (region)
Vellacott, Richard (Horizon Discovery 201207– CFO before VP Finance at CSR plc before Deloitte) Chief Financial Officer (CFO) Horizon Discovery (Group) East of England (region)
Venables, David (Synpromics 201508 CEO) Chief Executive Officer (CEO) Synpromics (Group) Scotland
Vendrell, Montserrat (Biocat 201203 CEO) Cluster Manager Biocat (BioRegion of Catalonia Private Foundation / Fundació Privada BioRegió de Catalunya) Catalonia
Venter, J. Craig n. a. VENTER Group [Craig Venter / Claire Fraser] (Group) Maryland (federal state)
Verhagen, Robert (Spectral Diagnostics 200606 VP BusDev) Business Development Manager / Strategy Manager Spectral Diagnostics Inc. (TSX: SDI) Ontario
Verhoef, Clarence (Varex Imaging 201701– CFO) Chief Financial Officer (CFO) Varex Imaging (Group) Utah (federal state)
Verjans, Benoît (Aseptic Technologies 200601 Commercial Director) n. a. GlaxoSmithKline (GSK) (Group) Belgium_o
Verleysen, Katleen (Pronota 201201– CEO before COO) Chief Executive Officer (CEO) MyCartis Flanders (Flemish region)
Vernon, N. Geoffrey n. a. Ziggus Holding Ltd. United Kingdom (state/region unspecified)
Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) Chief Executive Officer (CEO) Acorda Therapeutics (Group) Länsi-Suomi
Vertes, Akos (George Washington Univ 2000– Prof before Associate Prof since 1991) Professor George Washington University Maryland (federal state)
Viant, Mark (Univ Birmingham 201303 Professor) Professor University of Birmingham West Midlands (region)
Vicary, James (NuNano 201711 Managing Director + Co-Founder) Managing Director NuNano (GB) South West England (region)
Vick, Jeffery S. (Jeff) (Généthon 201509 Director BusDev before Flamel Technologies + Silence Therapeutics) Business Development Manager / Strategy Manager French Myopathy Association (AFM) Île-de-France (region)
Vickers, Philip J. (Shire 201202 SVP RnD at Shire Human Genetic Therapies) Research & Development Manager Shire (Group) Massachusetts (federal state)
Viehbacher, Christopher A. (Chris) (Bertarelli Group 201510 Managin Partner Gurnet Point Capital before Sanofi + GSK) Managing Partner BERTARELLI Group (family of Ernesto Bertarelli) Channel Islands (Non-Commonwealth / Non-EU tax haven)
Viey, Emilie (Ovizio Imaging Systems 201806– CEO before ACEA Biosciences + Roche Diagnostics France) Chief Executive Officer (CEO) Ovizio Imaging Systems NV/SA Brussels (region)
Vigodman, Erez (Teva 201608 CEO) Chief Executive Officer (CEO) Teva (Group) Israel_o
Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) Public Relations Manager / Investor Relations Manager Optimum Strategic Communications Greater London (region)
Villa, Laura (MolMed 201606 Investor Relations + Communication Director) Public Relations Manager / Investor Relations Manager MolMed S.p.A. (MLMD.MI) Lombardia (Lombardy)
Villette, Astrid (FTI Consulting 201612 FTI Consulting Paris) Public Relations Manager / Investor Relations Manager FTI Consulting (Group) Île-de-France (region)
VInce, Valérie (KWS Biotest 201511– Business Development Manager joined 2008 before Imperial College London) Business Development Manager / Strategy Manager Charles River (Group) South West England (region)
Viney, Jo (Biogen Idec 201311 VP Discovery Services) President/Director/Head Business Group/Unit/Division Biogen (Group) Massachusetts (federal state)
Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) Public Relations Manager / Investor Relations Manager Consilium Strategic Communications Ltd. (CSC) Greater London (region)
Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) Chief Executive Officer (CEO) Immunic AG Bayern (federal state)
Voglmaier, Manfred (Definiens –200411–200810 VP BusDev Life Sciences) Business Development Manager / Strategy Manager AstraZeneca (Group) Bayern (federal state)
Vogt, Reinhard (Sartorius 201308 Executive Board Member, Marketing, Sales, Services) Sales Manager / Marketing Manager Sartorius (Group) Niedersachsen (federal state)
Volanen, Jussi (Euformatics 201711 CTO before CEO) Chief Technology/Technical Officer (CTO) Euformatics Oy Uusimaa
Volck, Birgitte (GSK 201607– Head RnD Rare Diseases before Swedish Orphan Biovitrum 2012–201606 CMO) Research & Development Manager GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Volmer, Dietrich (Saarland Univ 201005– Professor for Analytical Chemistry before Univ Cambridge before Dalhousie Univ) Professor Saarland University (Universität des Saarlandes) Saarland (federal state)
von Emster, Kurt (Abingworth 201507– Managing Partner joined 201501 before venBio + MPM Capital + Franklin Templeton) Partner (venture partner) Abingworth (Group) California (federal state)
von Heijne, Johan (Ratos 201501 CEO of Biolin Scientific) Chief Executive Officer (CEO) Ratos (Group) Sweden_o
von Herrmann, Bruce (Agilent 200708 General Manager + VP Software Div) General Manager (management) Agilent (Group) California (federal state)
von Jako, Ron (GE Healthcare 200807 CMO + Surgical Developm Leader) Chief Medical Officer (CMO) General Electric (Group) South East England (region)
von Mangoldt, Karl (Protembis GmbH 2013– Managing Director + Co-Founder) Managing Director Protembis GmbH Hamburg (federal state)
von Rüden, Thomas (Direvo Biotech –201004 CEO STEPPED DOWN 4/19 before MorphoSys) Chief Executive Officer (CEO) Bayer (Group) Nordrhein-Westfalen (federal state)
von Volkmann, Christian (MagForce 201205– Head of Finance before Jerini CFO + Ernst & Young) Chief Financial Officer (CFO) MagForce (Group) Berlin (federal state)
von Will, Tristana (Biochrom Ltd 201306 Product Marketing Manager) Sales Manager / Marketing Manager Harvard Bioscience (Group) East of England (region)
Voskerchyan, Arman (Philips 201806 Business Leader for Therapeutic Care) Business Development Manager / Strategy Manager Philips (Group) North Brabant (province, NL)
Vosloo, Mark (Techcomp 201310– CEO of Edinburgh Instruments before Linos Photonics Ltd + Horiba Jobin Yvon Ltd) Chief Executive Officer (CEO) Techcomp (Group) Scotland
Vosloo, Nicola (PerkinElmer 201102 PerkinElmer (UK) Ltd) n. a. PerkinElmer (Group) South East England (region)
Vuillermet, Axelle (NewCap. 201203 Public Relations Manager) Public Relations Manager / Investor Relations Manager NewCap. – Investor Relations & Financial Communications Île-de-France (region)
Waanders, Gary (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) Managing Director Bryan, Garnier & Co., Ltd. Greater London (region)
Wade-Gery, Laura (Marks & Spencer + Tesco) Board member, non-executive Adaptimmune (Group) South East England (region)
Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations) Public Relations Manager / Investor Relations Manager Agilent (Group) California (federal state)
Wagner, David (GSK 201005 Section Manager DMPK Group) n. a. GlaxoSmithKline (GSK) (Group) United Kingdom (state/region unspecified)
Wake, Ashleigh (Intertek 201509 Biopharmaceutical Services Leder) President/Director/Head Business Group/Unit/Division Intertek (Group) North West England (region)
Wakefield, James (Novacyt 201704 Board Chairman) Board member, non-executive Novacyt (Group) Île-de-France (region)
Walbert, Timothy P. (Horizon Pharma 201003– CEO before IDM Pharma CEO before NeoPharm + Abbott) Chief Executive Officer (CEO) Takeda (Group) California (federal state)
next pagenext page 1 2 3 ... 32 33 34 35  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

» top